Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.
Journal: Cell chemical biology
Published: June 11, 2022
Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor.
Journal: Immunotherapy advances
Published: February 21, 2022
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.
Journal: Journal for immunotherapy of cancer
Published: January 08, 2022
Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 12, 2014
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.
Journal: The Journal of experimental medicine
Published: January 08, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026